neramexane mesylate

Small moleculeexperimental

Clinical trial activity

7 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
6
Phase 3
4
Phase 4
0

Earliest trial started May 1, 2008 (NCT00661440)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2008

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
Mol. weight
265.42 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • neramexane mesylate
  • neramexane mesylate
  • neramexane mesylate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00955799Phase 3Sep 1, 2009Merz
NCT00799942Phase 2May 1, 2009Merz
NCT00827008Phase 3Jan 1, 2009Merz
NCT00772980Phase 3Nov 1, 2008Merz
NCT00739635Phase 3Sep 1, 2008Merz
NCT00712283Phase 1Jul 1, 2008Merz
NCT00661440Phase 2May 1, 2008Merz, University of Leicester
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MerzFor profit7732008
University of LeicesterAcademic/Hospital1012008
2 organizations
Page 1 / 1